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Abstract The most frequent primary brain tumors, ana-
plastic astrocytomas (AA) and glioblastomas (GBM): tend
to invasion of the surrounding brain. Histopathological
studies found malignant cells in macroscopically unsuspi-
cious brain parenchyma remote from the primary tumor,
even affecting the contralateral hemisphere. In early stages,
diffuse interneural infiltration with changes of the apparent
diffusion coefficient (ADC) and fractional anisotropy (FA)
is suspected. The purpose of this study was to investigate
the value of DTI as a possible instrument of depicting
evidence of tumor invasion into the corpus callosum (CC).
Preoperatively, 31 patients with high-grade brain tumors (8
AA and 23 GBM) were examined by MRI at 3 T, applying
a high-resolution diffusion tensor imaging (DTI) sequence.
ADC- and FA-values were analyzed in the tumor-associ-
ated area of the CC as identified by fiber tracking, and were
compared to matched healthy controls. In (MR-)morpho-
logically normal appearing CC the ADC values were ele-
vated in the tumor patients (n = 22; 0.978 9 10-3 mm2/s)
compared to matched controls (0.917 9 10-3 mm2/s,
p \ 0.05), and the corresponding relative FA was reduced
(rFA: 88 %, p \ 0.01). The effect was pronounced in case
of affection of the CC visible on MRI (n = 9;
0.978 9 10-3 mm2/s, p \ 0.05; rFA: 72 % , p \ 0.01).
Changes in diffusivity and anisotropy in the CC can be
interpreted as an indicator of tumor spread into the con-
tralateral hemisphere not visible on conventional MRI.
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Introduction
Magnetic resonance imaging (MRI) plays a central role in
the staging and treatment of patients with brain tumors.
While conventional MRI with T2, FLAIR, and contrast-
enhanced T1-weighted sequences unravel the size, shape,
and structure of lesions, the use of perfusion- and diffusion-
weighted MRI adds information on the microstructural
architecture and regional blood flow.
The treatment of anaplastic astrocytomas and glioblas-
tomas first comprises a maximum surgical resection [1],
which is to be followed by radiation and chemotherapy.
Although affected patients often show only a small tumor
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burden and advanced imaging methods contribute to an
adequate diagnosis and tumor localization, higher-grade
astrocytomas are still considered incurable even when well
accessible for surgical and radiotherapeutic treatment [2].
The palliative treatment aims at maintaining the quality of
life with smallest neurological-cognitive deficits as long as
possible [3]. However, in these patients the median sur-
vival time is less than 2 years, and despite of general
advances in diagnosis and therapy, this poor prognosis has
improved only marginally during the past 30 years [4, 5].
Histopathological studies have reported the infiltrative
growth of glioblastoma multiforme (GBM) cells in appar-
ently unaffected brain regions remote from the confirmed
primary lesion [6–9] without correlating changes on com-
puted tomographic or MR images [10, 11]. Localized proton
MR spectroscopy (MRS) gives insights into tissue compo-
sition and intracellular metabolism and already provides
subtle hints about remote infiltration by GBM cells [12–14].
In early tumor stages, diffuse interneural infiltration with
changes of the apparent diffusion coefficient (ADC) and
fractional anisotropy (FA) is suspected. Pertinent alterations
were indeed observed by diffusion tensor imaging (DTI)
and/or MRS of normal appearing white matter in the
hemisphere contralateral to the actual glioma [12, 13].
In analogy to a previous case report [15] the purpose of
this study was to investigate the value of DTI as a possible




The local ethics committee approved this work according
to the declaration of Helsinki. Written informed consent
was obtained from all patients and control subjects. Over a
time period of 2 years pre-operative DTI was prospectively
performed in all consecutive cases of suspected brain
tumor before treatment. Only patients with post-operative
definite histopathological confirmation of a high grade
brain tumor (anaplastic astrocytoma WHO III or glio-
blastoma WHO IV) were included. Healthy age- and sex-
matched volunteers without any relevant medical history
served as normal controls. Data analyses were performed
retrospectively.
MRI
All studies were performed on the same 3T MR system
(Magnetom Trio, Siemens Medical Solutions, Erlangen/
Germany). Anatomical imaging included three-dimensional
(3D) T1-weighted (T1w) fast low-angle shot (FLASH) MRI
(time to repetition TR 11 ms; time to echo TE 4.9 ms; flip
angle 15; isotropic image resolution 1 9 1 9 1 mm3).
Diffusion tensor imaging employed a single-shot stimulated
echo acquisition mode (STEAM) sequence with 24 different
diffusion gradient directions (b-value 1,000 s/mm2, 38 axial
sections, 3 acquisitions) at 2.2 9 2.2 9 2.2 mm3 image
resolution. For further details see [15].
Image analysis
The image analyses were performed retrospectively. Dur-
ing post-processing the diffusion-weighted images were
smoothed with a 3D Gaussian filter (r = 2.2 mm). The
diffusion tensor was then calculated by a linear least-
squares algorithm using an in-house software (DeffCon
[16]). The tumor area was determined utilizing the clinical
MR study comprising FLAIR, T2, T1 before and after
gadolinium injection as well as perfusion and diffusion
weighted images and manually defined on the 3D T1w
datasets, and served as starting point for a fiber tracking
algorithm. The fiber tracts crossing the CC were utilized to
determine the region of the CC for the FA and ADC
analysis. In detail, fiber assignments were estimated from
the 3D FA values by a continuous axonal projection
tracking algorithm (FACT [17]). This algorithm terminated
the tracking of an individual fiber at FA-values below 0.15,
or if the local main diffusion tensor direction deviated more
than 40 in consecutive tracking steps [16]. In every sub-
ject, average FA- and ADC-values were quantified from
the midsagittal plane and both adjacent slices in the
affected parts of the CC, as localized by tractography.
To account for differences in absolute anisotropy in the
CC sections [16] and to facilitate group comparisons irre-
spective of the CC section affected, the FA data were
normalized by correlating to the individual FA-values of
the accordant CC section of the age- and sex-matched
control, referred to as relative fractional anisotropy (rFA).
Statistical analyses
Three groups were established according to the compre-
hensive analysis of the clinical MR study performed by two
experienced neuroradiologists in consensus and, additional
the medical history for group 3:
1. Tumor patients with obvious affection of the CC on
MRI (CC-affect),
2. Tumor patients without obvious affection of the CC
on MRI (CC-normal),
3. Age- and sex-matched healthy subjects in a control
group (control).
The ADC- and rFA-values from the patients and sub-
jects were analyzed by a paired student’s t test. The
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patients ‘‘CC-affect’’ and ‘‘CC-normal’’ were analyzed by
an unpaired student’s t test.
A survival analysis was performed by applying a log-
rank (Mantel-Cox) test, comparing the five patients with
the highest ADC-values to the five patients with the lowest
ADC-values. p-values \0.05 were regarded as significant.
Results
Demographic data
31 patients fulfilled the inclusion criteria and completed the
DTI measurement: 12 females, 19 males; mean age
56.9 years, range [22–77 years]. The post-operative
neuropathological diagnosis was anaplastic astrocytoma
(WHO III) in 8 cases and glioblastoma multiforme (WHO
IV) in 23 cases. DTI datasets of healthy age- and sex-
matched volunteers served as control (mean age
58.7 years, range [23–81 years]).
Apparent diffusion coefficient
In the control subjects the ADC-values showed a non-
significant trend to increase with age (r = 0.31, p = 0.14).
Compared to the healthy controls, the ADC-values in the
tumor patients rendered more inhomogeneous results,
specifically if the CC was affected according to MRI (CC-
affect). The patients’ ADC-values were significantly higher
relative to controls (p \ 0.05) (Table 1). Within the patient
group, the presence of CC infiltration had no effect on the
ADC-values, i.e. the average ADC-values in CC-affect or
CC-normal patients were almost similar (0.97769 9 10-3
vs 0.97786 9 10-3 mm2/s; p = 0.498).
Relative fractional anisotropy
Regarding normal controls and the CC areas of patients not
related to the tumor FA values significantly decreased with
age (r = -0.59, p \ 0.01).
There was a significant rFA reduction in the tumor
corresponding region of the CC of both patient groups
compared to controls (Table 2) and comparing the patients
with CC affection to those with inconspicuous CC (Fig. 1).
Survival data
There was no significant difference between patients with
CC infiltration compared to those without (median survival
time: CC-affect 335.0 days vs CC-normal 358.5 days;
p [ 0.05). However, among the patients without CC infil-
tration the five patients with the lowest ADC-values tended
to live longer than the five patients with the highest ADC-
values (Fig. 2); median survival time: ‘‘ADC high’’
157.0 days, ‘‘ADC low’’ 413.0 days; p \ 0.05. There was
no significant difference between the two groups regarding
tumor size, resection or therapy.
Illustrative case
In order to illustrate possible infiltration patterns of
malignant brain tumors, Fig. 3 shows pre-operative and
Table 1 ADC-values in the corpus callosum associated to the glioma
location compared to healthy age- and sex-matched controls
ADC (95 % CI)
(910-3 mm2/s)
p









95 % CI = 95 % confidence interval
Table 2 Relative FA (rFA) values in the corpus callosum associated
to the glioma location with (CC-affect) and without (CC-normal)
obvious affection of the CC compared to healthy age- and sex-mat-
ched controls
rFA (95 % CI) p













Fig. 1 Boxplot of rFA values of patients with (CC-affect) and without
(CC-normal) obvious affection of the corpus callosum and healthy
controls demonstrating significant asterisk differences between the two
patient groups and controls as well as between the patient groups
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follow-up T1-weighted MRI of a 65 year-old female with
newly diagnosed GBM. At first, tumor growth was limited
to the right hemisphere and fiber-tracking revealed tumor-
associated nerve fibers crossing the trunk of the CC as
shown below. With the tumor growth progressing despite
surgery and concomitant radio-chemotherapy, post-opera-
tive follow-up examination displayed enhancement of
contrast agent in those regions of the CC which showed to
contain fibers connecting the primary focus with the con-
tralateral hemisphere 10 month before.
Discussion
Only about 2 % of patients with high-grade brain tumors
survive the first 5 years after diagnosis [18]. One of the
main factors for the poor prognosis of glioblastomas is the
invasiveness of malignant cells [19]. Histopathological
studies showed glioma cells remote [6, 10] from the his-
tologically identical main tumor bulk [9] only to differ in
growth rate. These infiltrating glioma cells can hardly be
imaged by standard techniques [11]. However, diffusion
and metabolic abnormalities detected by DWI/DTI and
proton MRS were found outside the borders of malignant
brain tumors defined by conventional MRI as potential
indicators of tumor infiltration or malignant transformation
[12, 13, 20].
A number of effects may account for the increase of
ADC-values in the section of the CC corresponding to the
tumor location: An interaction of tumor cells with the
extracellular matrix (ECM) is mandatory to enable cell
migration. The invasiveness depends on destruction of
Fig. 2 The Kaplan–Meier-curve comparing the five patients with the
lowest ADC-values to the five patients with highest ADC-values and
without visible CC infiltration demonstrates a longer survival with
low or normal ADC-values
Fig. 3 The 3D-fiber tracts are projected on the sagittal midline
2D-image from the T1 dataset demonstrating the localization of the
passage of the CC (a). The fiber tracts originating from a glioblastoma
crossing the truncus of the CC—marked in solid red (b)—identify an
area mainly in region 2 [16] marked in light blue (b)—Without any
abnormal signal or contrast enhancement (c). The follow-up exam-
ination 12 months later reveals recurrent tumor infiltrating of the CC
with contrast enhancement in the previously identified area (d)
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ECM components as well as on penetration between
adjacent normal brain structures [21]. Glioma cells initially
infiltrate or spread micro-invasively between and around
neurons and penetrate into the fiber tracts of white matter
[22], causing a local displacement of the normal paren-
chyma without neuronal damage [23]. Then the local brain
tissue is untightened and displaced under the influence of
proteases [24]. Furthermore, the growth of a tumor in the
CNS is associated with a disturbance of the blood–brain
barrier, which leads to a vasogenic edema and an increase
in parenchymal water content, which in turn increases the
extracellular space and the corresponding ADC-value [25].
While disease advances, nerve cells may be destroyed
and replaced by tumor cells [22]. This results in a decrease
of ADC-values [26] and explains the ADC inhomogenei-
ties among cases where MRI depicted infiltration of the
CC. Regarding fractional anisotropy, a negative correlation
between FA values versus cellular density and rate of
tumor infiltration has been reported [27, 28], corresponding
to our findings.
Abnormal FA- or ADC-values support [29] but do not
prove glioma invasion since ADC cannot definitely differ-
entiate between tumor and edema [30]. Corresponding to our
data, however: tumor recurrence frequently occurs in areas
of previously enhanced diffusivity, especially if fiber track-
ing suggests a connection to the tumor [31]. Unfortunately,
only a small number of patients survived long enough to be
monitored for consecutive tumor infiltration into the CC.
Limitations
Age- and sex-matched healthy individuals served as controls
to minimize potential influences on DTI values [32, 33].
According to ethical considerations no specimen from
normal appearing parenchyma of the corpus callosum was
collected for histopathological analysis.
Conclusion
In patients with malignant gliomas brain tumors, analyzing
the CC which connects both hemispheres is of major
importance, since its infiltration indicates tumor spread into
the contralateral hemisphere which in turn downgrades the
prognosis. Our data suggest that changes in ADC and in FA
in the tumor corresponding areas of the CC may be an early
indicator for tumor cell infiltration in those areas. Larger
clinical follow-up studies are required to confirm this
postulation, because it may have a large impact on prog-
nosis and therapy.
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